Dynamic full-field optical coherence tomography module adapted to commercial microscopes allows longitudinal in vitro cell culture study.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
28 09 2023
Historique:
received: 24 02 2023
accepted: 20 09 2023
medline: 2 10 2023
pubmed: 29 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Dynamic full-field optical coherence tomography (D-FFOCT) has recently emerged as a label-free imaging tool, capable of resolving cell types and organelles within 3D live samples, whilst monitoring their activity at tens of milliseconds resolution. Here, a D-FFOCT module design is presented which can be coupled to a commercial microscope with a stage top incubator, allowing non-invasive label-free longitudinal imaging over periods of minutes to weeks on the same sample. Long term volumetric imaging on human induced pluripotent stem cell-derived retinal organoids is demonstrated, highlighting tissue and cell organization processes such as rosette formation and mitosis as well as cell shape and motility. Imaging on retinal explants highlights single 3D cone and rod structures. An optimal workflow for data acquisition, postprocessing and saving is demonstrated, resulting in a time gain factor of 10 compared to prior state of the art. Finally, a method to increase D-FFOCT signal-to-noise ratio is demonstrated, allowing rapid organoid screening.

Identifiants

pubmed: 37770552
doi: 10.1038/s42003-023-05378-w
pii: 10.1038/s42003-023-05378-w
pmc: PMC10539404
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

992

Informations de copyright

© 2023. Springer Nature Limited.

Références

Appl Spectrosc. 2011 Sep;65(9):967-80
pubmed: 21929850
Photochem Photobiol Sci. 2010 Dec;9(12):1634-9
pubmed: 20931137
J Immunol. 2010 Jul 1;185(1):64-70
pubmed: 20498360
Nat Rev Mol Cell Biol. 2017 Dec;18(12):771-783
pubmed: 28974772
Elife. 2020 Oct 14;9:
pubmed: 33052099
Front Cell Dev Biol. 2021 Dec 17;9:738786
pubmed: 34977004
Bioinformatics. 2017 Aug 01;33(15):2424-2426
pubmed: 28369169
J Vis Exp. 2017 Nov 1;(129):
pubmed: 29155748
Sci Rep. 2017 Jun 23;7(1):4165
pubmed: 28646146
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3311-3318
pubmed: 28672397
Biomed Opt Express. 2022 May 05;13(6):3187-3194
pubmed: 35781969
Stem Cells. 2017 May;35(5):1176-1188
pubmed: 28220575
Cell Stem Cell. 2012 Jun 14;10(6):771-785
pubmed: 22704518
Phys Med Biol. 2004 Apr 7;49(7):1227-34
pubmed: 15128200
Nat Rev Mol Cell Biol. 2017 Dec;18(12):728-742
pubmed: 29115301
Nat Cell Biol. 2016 Mar;18(3):246-54
pubmed: 26911908
MethodsX. 2019 Oct 18;6:2468-2475
pubmed: 31720237
Biomed Opt Express. 2019 Jan 22;10(2):731-746
pubmed: 30800511
Anal Biochem. 2009 Mar 1;386(1):105-12
pubmed: 19111514
Sci Rep. 2022 Jan 27;12(1):1488
pubmed: 35087119
Cell Death Dis. 2019 Feb 27;10(3):201
pubmed: 30814510
J Med Imaging (Bellingham). 2023 May;10(3):034504
pubmed: 37274760
Science. 2002 Nov 8;298(5596):1241-5
pubmed: 12424381
Opt Lett. 1998 Feb 15;23(4):244-6
pubmed: 18084473
Nat Commun. 2015 Jun 25;6:7525
pubmed: 26109233
Commun Biol. 2022 Oct 27;5(1):1135
pubmed: 36302949
Redox Biol. 2017 Aug;12:462-468
pubmed: 28334681
Commun Biol. 2022 Jun 10;5(1):575
pubmed: 35688936
Dermatology. 2012;224(1):84-92
pubmed: 22487768
Stem Cell Rev Rep. 2016 Oct;12(5):553-559
pubmed: 27435468
Biomed Opt Express. 2016 Mar 24;7(4):1511-24
pubmed: 27446672
Bioessays. 2017 Aug;39(8):
pubmed: 28749075
J Pathol Inform. 2011;2:28
pubmed: 21773059
Nat Methods. 2018 Jan 3;15(1):24-26
pubmed: 29298292
Cell Chem Biol. 2022 Jan 20;29(1):120-132.e4
pubmed: 34739851
Methods Cell Biol. 2014;123:77-94
pubmed: 24974023
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Nat Methods. 2005 Dec;2(12):910-9
pubmed: 16299476
Nat Methods. 2018 Mar;15(3):173-182
pubmed: 29377014
PLoS Biol. 2014 Feb 11;12(2):e1001788
pubmed: 24523664
Phys Chem Chem Phys. 2006 Aug 14;8(30):3486-95
pubmed: 16871337
eNeuro. 2018 Jun 29;5(3):
pubmed: 29971247
Anat Rec (Hoboken). 2013 Jan;296(1):1-8
pubmed: 22907880
Dis Model Mech. 2011 Mar;4(2):165-78
pubmed: 21324931
Sci Rep. 2017 Jul 10;7(1):4988
pubmed: 28694478
Nat Commun. 2022 Aug 18;13(1):4864
pubmed: 35982061
BMC Biol. 2021 Feb 24;19(1):37
pubmed: 33627108
Transfusion. 2018 Jul;58(7):1800-1813
pubmed: 29672857
J Appl Physiol (1985). 2009 Aug;107(2):613-20
pubmed: 19498100
Nat Rev Drug Discov. 2008 Dec;7(12):979-87
pubmed: 19043449
Development. 2019 Jan 9;146(1):
pubmed: 30567931
Cell. 2019 Jan 24;176(3):419-434
pubmed: 30682370
Science. 2005 Sep 16;309(5742):1857-61
pubmed: 16166517
Nat Rev Mol Cell Biol. 2017 Nov;18(11):685-701
pubmed: 28875992
J Cell Sci. 2007 Oct 1;120(Pt 19):3372-83
pubmed: 17881499
Arch Pathol Lab Med. 2019 Mar;143(3):288-298
pubmed: 30525931
Light Sci Appl. 2020 Aug 17;9:140
pubmed: 32864115
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4605-4615
pubmed: 28892117
Biomed Opt Express. 2016 Oct 07;7(11):4501-4513
pubmed: 27895991
Nat Methods. 2017 Jun 29;14(7):657-661
pubmed: 28661494
NPJ Regen Med. 2022 Aug 16;7(1):39
pubmed: 35974011
Front Immunol. 2019 Apr 11;10:755
pubmed: 31031756
Annu Rev Neurosci. 1989;12:227-53
pubmed: 2648950
Curr Protoc Mol Biol. 2010 Oct;Chapter 14:Unit14.20
pubmed: 20890901
J Cell Biol. 2019 May 6;218(5):1452-1466
pubmed: 30894402
Commun Biol. 2021 Apr 15;4(1):477
pubmed: 33859337
RNA Biol. 2018;15(6):787-796
pubmed: 29658398
Nat Rev Methods Primers. 2021;1:
pubmed: 35663461
Arch Pathol Lab Med. 2019 Sep;143(9):1058-1068
pubmed: 31295016
Annu Rev Physiol. 2017 Feb 10;79:93-117
pubmed: 27860833
Sci Rep. 2018 Sep 28;8(1):14520
pubmed: 30266927
Int Rev Cell Mol Biol. 2009;276:49-103
pubmed: 19584011
STAR Protoc. 2022 Apr 22;3(2):101347
pubmed: 35509972
Stem Cells Int. 2019 Jul 15;2019:7858796
pubmed: 31396286
Trends Neurosci. 2018 Dec;41(12):880-884
pubmed: 30287084
J Vis Exp. 2018 Sep 6;(139):
pubmed: 30247478
Sci Rep. 2021 Feb 24;11(1):4409
pubmed: 33627679
Cell Transplant. 2017 Jun 9;26(6):1089-1102
pubmed: 28139195
Appl Opt. 2002 Feb 1;41(4):805-12
pubmed: 11993929
Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8518-23
pubmed: 24912154
Med Sci (Paris). 2020 Jun-Jul;36(6-7):626-632
pubmed: 32614314
Science. 2004 Oct 22;306(5696):704-8
pubmed: 15499023

Auteurs

Tual Monfort (T)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France.
CHNO des Quinze-Vingts, INSERM-DGOS CIC 1423, 28 rue de Charenton, F-75012, Paris, France.
Paris Eye Imaging Group, Quinze-Vingts National Eye Hospital, INSERM-DGOS, CIC 1423, 28 rue de Charenton, Paris, 75012, France.

Salvatore Azzollini (S)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France.

Jérémy Brogard (J)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France.

Marilou Clémençon (M)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France.

Amélie Slembrouck-Brec (A)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France.

Valerie Forster (V)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France.

Serge Picaud (S)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France.

Olivier Goureau (O)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France.

Sacha Reichman (S)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France.

Olivier Thouvenin (O)

Institut Langevin, ESPCI Paris, Université PSL, CNRS, 75005, Paris, France.

Kate Grieve (K)

Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012, Paris, France. kate.grieve@inserm.fr.
CHNO des Quinze-Vingts, INSERM-DGOS CIC 1423, 28 rue de Charenton, F-75012, Paris, France. kate.grieve@inserm.fr.
Paris Eye Imaging Group, Quinze-Vingts National Eye Hospital, INSERM-DGOS, CIC 1423, 28 rue de Charenton, Paris, 75012, France. kate.grieve@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH